Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Wetzels

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Kidney Journal|September 29, 2015
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN studyJorge Rojas-Rivera, Gema Fernández-Juárez, Alberto Ortiz, et al.
BMC Nephrology|October 30, 2017
Differential diagnosis of thrombotic microangiopathy in nephrologyT Sakari Jokiranta, Ondrej Viklicky, Saleh Al Shorafa, et al.
Plos One|May 10, 2019
Predicting kidney failure from longitudinal kidney function trajectory: A comparison of modelsJan A J G van den Brand, Tjeerd M H Dijkstra, Jack Wetzels, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2018
Neuropeptide Y and chronic kidney disease progression: a cohort studyCarmine Zoccali, Graziella D'Arrigo, Daniela Leonardis, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2012
Subtotal ablation of parietal epithelial cells induces crescent formationEva-Maria Sicking, Astrid Fuss, Sandra Uhlig, et al.
The American Journal of Pathology|October 14, 2014
Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change diseaseBart Smeets, Fabien Stucker, Jack Wetzels, et al.
Frontiers in Immunology|September 7, 2021
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 GlomerulopathiesMarkus A Loeven, Marissa L Maciej-Hulme, Cansu Yanginlar, et al.
The Patient|March 31, 2017
Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire)Merel L Kimman, Adrienne H Rotteveel, Marlies Wijsenbeek, et al.
Kidney International|February 16, 2020
The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseasesCamille Macé, Maria Del Nogal Avila, Caroline B Marshall, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2009
Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritisBart Smeets, Maria Lucia Angelotti, Paola Rizzo, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|September 29, 2015
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN studyJorge Rojas-Rivera, Gema Fernández-Juárez, Alberto Ortiz, et al.
BMC Nephrology|October 30, 2017
Differential diagnosis of thrombotic microangiopathy in nephrologyT Sakari Jokiranta, Ondrej Viklicky, Saleh Al Shorafa, et al.
Plos One|May 10, 2019
Predicting kidney failure from longitudinal kidney function trajectory: A comparison of modelsJan A J G van den Brand, Tjeerd M H Dijkstra, Jack Wetzels, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2018
Neuropeptide Y and chronic kidney disease progression: a cohort studyCarmine Zoccali, Graziella D'Arrigo, Daniela Leonardis, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2012
Subtotal ablation of parietal epithelial cells induces crescent formationEva-Maria Sicking, Astrid Fuss, Sandra Uhlig, et al.
The American Journal of Pathology|October 14, 2014
Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change diseaseBart Smeets, Fabien Stucker, Jack Wetzels, et al.
Frontiers in Immunology|September 7, 2021
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 GlomerulopathiesMarkus A Loeven, Marissa L Maciej-Hulme, Cansu Yanginlar, et al.
The Patient|March 31, 2017
Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire)Merel L Kimman, Adrienne H Rotteveel, Marlies Wijsenbeek, et al.
Kidney International|February 16, 2020
The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseasesCamille Macé, Maria Del Nogal Avila, Caroline B Marshall, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2009
Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritisBart Smeets, Maria Lucia Angelotti, Paola Rizzo, et al.
Pageof 4